Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaokun Shu

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 8, 2017
BET Bromodomain Proteins as Cancer Therapeutic TargetsShaokun Shu, Kornelia Polyak
Innovation (Cambridge (Mass.))|September 11, 2020
Therapy of Primary Liver CancerMei Feng, Yisheng Pan, Ruirui Kong, et al.
Plos One|May 22, 2013
IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic functionJian-Ping Guo, Wei Tian, Shaokun Shu, et al.
Plos One|March 17, 2010
Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathwayDonghwa Kim, Shaokun Shu, Marc D Coppola, et al.
Experimental Hematology & Oncology|February 6, 2021
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomasYingying Ye, Ning Ding, Lan Mi, et al.
Journal of Proteome Research|March 1, 2007
Seeking transformation markers: an analysis of differential tissue proteomes on the rice germplasm generated from transformation of Echinochloa crusgalli genomic DNACaifeng Zhao, Bingran Zhao, Yan Ren, et al.
The Journal of Biological Chemistry|November 27, 2009
Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120Zengqiang Yuan, Donghwa Kim, Shaokun Shu, et al.
Genome Biology|April 6, 2023
FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5'-end single-cell RNA sequencingYun Li, Zheng Huang, Zhaojun Zhang, et al.
Current Cancer Drug Targets|February 22, 2008
Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discoveryGeorge Z Cheng, Sungman Park, Shaokun Shu, et al.
Nature Methods|July 18, 2024
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenomeChao Dong, Xiaoxuan Meng, Tong Zhang, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cold Spring Harbor Symposia on Quantitative Biology|January 8, 2017
BET Bromodomain Proteins as Cancer Therapeutic TargetsShaokun Shu, Kornelia Polyak
Innovation (Cambridge (Mass.))|September 11, 2020
Therapy of Primary Liver CancerMei Feng, Yisheng Pan, Ruirui Kong, et al.
Plos One|May 22, 2013
IKBKE phosphorylation and inhibition of FOXO3a: a mechanism of IKBKE oncogenic functionJian-Ping Guo, Wei Tian, Shaokun Shu, et al.
Plos One|March 17, 2010
Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathwayDonghwa Kim, Shaokun Shu, Marc D Coppola, et al.
Experimental Hematology & Oncology|February 6, 2021
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomasYingying Ye, Ning Ding, Lan Mi, et al.
Journal of Proteome Research|March 1, 2007
Seeking transformation markers: an analysis of differential tissue proteomes on the rice germplasm generated from transformation of Echinochloa crusgalli genomic DNACaifeng Zhao, Bingran Zhao, Yan Ren, et al.
The Journal of Biological Chemistry|November 27, 2009
Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120Zengqiang Yuan, Donghwa Kim, Shaokun Shu, et al.
Genome Biology|April 6, 2023
FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5'-end single-cell RNA sequencingYun Li, Zheng Huang, Zhaojun Zhang, et al.
Current Cancer Drug Targets|February 22, 2008
Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discoveryGeorge Z Cheng, Sungman Park, Shaokun Shu, et al.
Nature Methods|July 18, 2024
Single-cell EpiChem jointly measures drug-chromatin binding and multimodal epigenomeChao Dong, Xiaoxuan Meng, Tong Zhang, et al.
Pageof 3